INS and Hyperglycemia: Owing to the characteristics of currently available insulins, it may be inevitable that increased hyperglycemia will be experienced with a missed bolus; however, an AP system is expected to reduce the severity and duration of hyperglycemia as compared with what would be observed with a missed bolus in OL therapy.